A Multi-Center Protocol for Obtaining and Storing Human Samples for Immediate or Future Microbial, Immune, or Host-Microbe Scientific Study
NCT00764023 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 97
Last updated 2015-11-26
Summary
The intent of this protocol is to salvage human-related material that is normally destined for destruction, so it can be used in infection-related scientific studies. This clinical material can be studied in order to better understand the molecular, cellular, or ecological components of the infected or potentially infected tissue or device.
Conditions
Sponsors & Collaborators
-
Southwest Regional Wound Care Center
lead OTHER
Principal Investigators
-
Randall Wolcott, MD · Southwest Regional Wound Care Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-03-31
- Primary Completion
- 2013-01-31
- Completion
- 2013-01-31
Countries
- United States
Study Locations
More Related Trials
-
Collection of Human Biological Samples for the Development and Validation of New Methods of Diagnosis and for the Realization of Expertises Diagnostics in the Field of Infectious Diseases and Tropical
NCT03912246 ·Status: COMPLETED ·Phase: NA
-
Compliant Analysis of Patient Samples and Data
NCT04364503 ·Status: RECRUITING
-
Optimization of Collection Methods for Studies of the Human Microbiota
NCT03731702 ·Status: WITHDRAWN
-
Device to Reduce Surgery Site Contamination
NCT00972153 ·Status: COMPLETED ·Phase: NA
-
Non-invasive Sampling Method for Skin Test: Optimization of Sample Collection and Extraction
NCT07117747 ·Status: COMPLETED ·Phase: NA
-
COVID-19 Immunity Assessment
NCT05080231 ·Status: COMPLETED
-
A Study to Assess Recovery and Survival of Radiolabeled Apheresis Platelet Components Treated With the INTERCEPT Blood System for Platelets With LED Illuminator.
NCT06697223 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Long COVID Symptoms Utilizing Autologous Stem Cells Following COVID-19 Infection
NCT05669261 ·Status: UNKNOWN ·Phase: PHASE1
-
Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 (COVID-19) IgG Antibody Test in Fingerstick Whole Blood
NCT04699903 ·Status: COMPLETED
-
Point-spectroscopy Trial
NCT05183698 ·Status: UNKNOWN
-
Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19
NCT04434131 ·Status: COMPLETED ·Phase: PHASE2
-
Components of Chlorhexidine Gluconate Dressing
NCT01112020 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Stability of Mail-in Capillary Hemoglobin A1c Test Kit
NCT00511030 ·Status: COMPLETED
-
Acquiring Convalescent Specimens for COVID-19 Antibodies
NCT04342195 ·Status: COMPLETED
-
MolecuLightDX Measurement Feature Clinical Validation
NCT06682923 ·Status: RECRUITING
-
Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use
NCT00001846 ·Status: RECRUITING
-
Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Specimens for Research Studies
NCT00067054 ·Status: RECRUITING
-
Research on the Localization Accuracy of PICC Guided by EDUG in Real World
NCT03230357 ·Status: UNKNOWN ·Phase: NA
-
A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate
NCT01934842 ·Status: WITHDRAWN ·Phase: NA
-
Control of Leukocyte Function
NCT03027232 ·Status: COMPLETED
-
COVID-19 And Geko Evaluation: The CAGE Study
NCT04651374 ·Status: WITHDRAWN ·Phase: NA
-
Study of Accuracy of New Diagnostic Technology to Guide Rapid Antibiotic Treatment for Serious Infections
NCT02796716 ·Status: COMPLETED
-
Alinity s Anti-HCV II - Clinical Evaluation Protocol
NCT04862065 ·Status: COMPLETED ·Phase: NA
-
Convalescent Plasma Collection and Treatment in Pediatrics and Adults
NCT04376034 ·Status: RECRUITING ·Phase: PHASE3
-
Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test
NCT04597047 ·Status: UNKNOWN ·Phase: NA